Асосий контентга ўтиш
AkademIndex

Маҳсулотлар

Ишлаб чиқувчилар учун

AkademBaseЭкотизим учун очиқ API
← Ишга қайтиш

Ушбу иш иқтибос қилган ишлар

248 та иш

Иш: siRNA-based strategies to combat drug resistance in gastric cancer

  1. Clinical Pharmacokinetics of Doxorubicin

    P A Speth, Q.G.C.M. van Hoesel, C. Haanen

    Шарҳ мақола19882 иқтибос
    ABI

  2. Targeting EZH2 in cancer

    Kimberly H. Kim, Charles W.M. Roberts

    Шарҳ мақола20162 иқтибос
    ABI

  3. LncRNA UCA1 in anti-cancer drug resistance

    Haohao Wang, Zhonghai Guan, Kuifeng He +3

    Шарҳ мақола20172 иқтибос
    ABI

  4. Epithelial Mesenchymal Transition in Tumor Metastasis

    Vivek Mittal

    Шарҳ мақола20182 иқтибос
    ABI

  5. Circular RNA circNRIP1 acts as a microRNA-149-5p sponge to promote gastric cancer progression via the AKT1/mTOR pathway

    Xing Zhang, Sen Wang, Haixiao Wang +8

    Мақола20192 иқтибос
    ABI

  6. Noncoding RNAs in gastric cancer: implications for drug resistance

    Ling Wei, Jujie Sun, Nasha Zhang +7

    Шарҳ мақола20202 иқтибос
    ABI

  7. LncRNA UCA1 promotes cisplatin resistance in gastric cancer via recruiting EZH2 and activating PI3K/AKT pathway

    Qingqiang Dai, Tianqi Zhang, Jiaomeng Pan +1

    Мақола20202 иқтибос
    ABI

  8. EZH2: a novel target for cancer treatment

    Ran Duan, Wenfang Du, Weijian Guo

    Шарҳ мақола20202 иқтибос
    ABI

  9. Pepsinogen C expression–related lncRNA/circRNA/mRNA profile and its co-mediated ceRNA network in gastric cancer

    Lirong Yan, Han-xi Ding, Shixuan Shen +3

    Мақола20212 иқтибос
    ABI

  10. Emerging roles of circular RNAs in gastric cancer metastasis and drug resistance

    Xiaolin Wang, Jiahui Zhang, Guozhen Cao +3

    Шарҳ мақола20222 иқтибос
    ABI

  11. Restoration of miR-648 overcomes 5-FU-resistance through targeting ET-1 in gastric cancer cells in-vitro

    Parsa Aliabadi, Maryam Sadri, Goli Siri +8

    Мақола20222 иқтибос
    ABI

  12. Targeting cell death pathways for cancer therapy: recent developments in necroptosis, pyroptosis, ferroptosis, and cuproptosis research

    Xuhui Tong, Rong Tang, Mingming Xiao +6

    Шарҳ мақола20222 иқтибос
    ABI

  13. FAM117B promotes gastric cancer growth and drug resistance by targeting the KEAP1/NRF2 signaling pathway

    Yunjiang Zhou, Yaxin Chen, Yongwei Shi +6

    Мақола20232 иқтибос
    ABI

  14. CircRNA: A new class of targets for gastric cancer drug resistance therapy

    Ying Zheng, Zhe Li, Yao Wang +4

    Шарҳ мақола20232 иқтибос
    ABI

  15. Deciphering drug resistance in gastric cancer: Potential mechanisms and future perspectives

    Jiahua Liu, Qihang Yuan, Hui Guo +3

    Мақола20242 иқтибос
    ABI

  16. Nanoparticles in tumor microenvironment remodeling and cancer immunotherapy

    Qiang Lü, Dongquan Kou, Shenghan Lou +13

    Мақола20242 иқтибос
    ABI

  17. Сарлавҳасиз

    Бошқа2 иқтибос
    ABI

  18. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI

  19. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI

  20. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI

  21. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI

  22. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI

  23. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI

  24. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI

  25. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI